Charles Olson Net Worth

The estimated Net Worth of Charles W Olson is at least $6.92 million dollars as of 16 August 2024. Mr. Olson owns over 18,447 units of Surmodics stock worth over $2,773,483 and over the last 21 years he sold SRDX stock worth over $3,243,701. In addition, he makes $903,229 as Senior Vice President of Commercial and Business Development et Medical Devices at Surmodics.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Olson SRDX stock SEC Form 4 insiders trading

Charles has made over 25 trades of the Surmodics stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 18,447 units of SRDX stock worth $612,440 on 16 August 2024.

The largest trade he's ever made was exercising 47,347 units of Surmodics stock on 27 March 2018 worth over $820,997. On average, Charles trades about 4,072 units every 99 days since 2004. As of 16 August 2024 he still owns at least 70,698 units of Surmodics stock.

You can see the complete history of Mr. Olson stock trades at the bottom of the page.

Charles Olson biography

Charles W. Olson serves as Senior Vice President of Commercial and Business Development, Medical Devices of the Company. In April 2005, the position of Vice President, Sales was added to his responsibilities. In November 2008, Mr. Olson was named Vice President of our Cardiovascular business unit, in October 2010, he was named Senior Vice President and General Manager, Medical Device, and in August 2016 he was named Senior Vice President of Commercial and Business Development, Medical Devices. Prior to joining Surmodics, Mr. Olson was employed as General Manager at Minnesota Extrusion from 1998 to 2001 and at Lake Region Manufacturing in project management and technical sales from 1993 to 1998.

What is the salary of Charles Olson?

As the Senior Vice President of Commercial and Business Development et Medical Devices of Surmodics, the total compensation of Charles Olson at Surmodics is $903,229. There are 3 executives at Surmodics getting paid more, with Gary Maharaj having the highest compensation of $2,343,630.

How old is Charles Olson?

Charles Olson is 55, he's been the Senior Vice President of Commercial and Business Development et Medical Devices of Surmodics since 2016. There are 12 older and 7 younger executives at Surmodics. The oldest executive at Surmodics, Inc. is David Dantzker, 76, who is the Independent Director.

What's Charles Olson's mailing address?

Charles's mailing address filed with the SEC is 9924, West 74th Street, Eden Prairie, Hennepin County, Minnesota, 55344, United States of America.

Insiders trading at Surmodics

Over the last 21 years, insiders at Surmodics have traded over $26,204,565 worth of Surmodics stock and bought 19,725 units worth $436,251 . The most active insiders traders include Jeffrey C Smith, Gary R Maharaj et Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of $415,014. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth $706,662.

What does Surmodics do?

surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.

Complete history of Mr. Olson stock trades at Surmodics

Surmodics executives and stock owners

Surmodics executives and other stock owners filed with the SEC include:

• Gary Maharaj,
  President, Chief Executive Officer, Director
• Gary R. Maharaj,
  CEO, Pres & Director
• Teri Sides,
  Senior Vice President, Chief Marketing Officer
• Charles Olson,
  Senior Vice President of Commercial and Business Development, Medical Devices
• Gregg Sutton,
  Vice President - Research and Development, Medical Devices
• Thomas Greaney,
  Chief Operating Officer, Medical Devices
• Timothy Arens,
  Chief Financial Officer, Vice President - Finance
• Joseph Stich,
  Vice President, General Manager - In Vitro Diagnostics
• Gordon S. Weber,
  Sr. VP of Legal, Gen. Counsel & Sec.
• Timothy J. Arens,
  Sr. VP of Fin. & Information Technology and CFO
• Joseph J. Stich,
  Sr. VP and GM of HR & In Vitro Diagnostics
• Teryl L. W. Sides,
  Sr. VP of Product Devel. & Chief Marketing Officer
• Susan Knight,
  Non-Executive Independent Chairman of the Board
• Ronald Kalich,
  Independent Director
• David Dantzker,
  Independent Director
• Jose Bedoya,
  Independent Director
• Shawn McCormick,
  Independent Director
• Lisa Heine,
  Independent Director
• Nusrath Sultana,
  Vice President - Clinical Affairs
• Gordon Weber,
  Senior Vice President - Legal, General Counsel, Secretary
• Gregg S. Sutton,
  VP of R&D - Medical Devices
• Charles W. Olson,
  Sr. VP of Commercial & Bus. Devel. of Medical Devices
• John D. Manders,
  Corp. Controller & Principal Accounting Officer
• Lise W Duran,
  VP Product Development
• Andrew D. C. La Frence,
  VP of Finance & CFO
• Amy E. Seibert,
  Principal Accounting Officer
• Michael J Shoup,
  Vice President
• Douglas P Astry,
  General Manager
• Aron B Anderson,
  VP & Chief Scientific Officer
• John C. Middleton,
  VP, Drug Del, Product Dev
• Brian L Robey,
  Vice President
• Paul A Lopez,
  Vice President
• Bruce Barclay,
  President & COO
• John D. Manders,
  Corporate Controller
• Steven J Keough,
  VP & Chief IP Counsel
• Peter L Ginsberg,
  Vice President
• Bryan K Phillips,
  SVP, Gen Counsel & Secretary
• Kendrick B Melrose,
  Director
• David A Koch,
  Director
• Dale R Olseth,
  Chairman and CEO
• Loren R Miller,
  Vice President and Controller
• David S Wood,
  VP & GM - Drug Del. Bus. Unit
• Patrick E Guire,
  Senior Vice President
• Gregory T Yung,
  VP Sales & Business Developmen
• Ronald F Ofstead,
  VP Chemistry Development
• Richard C Carlson,
  VP of Strategic Planning
• Jane M Nichols,
  Vice President Marketing
• Marie J Versen,
  Vice President
• John W Benson,
  Director
• Mary K Brainerd,
  Director
• Mark A. Lehman,
  Treasurer
• Scott R. Ward,
  Director
• Gerald B Fischer,
  Director
• Timothy S Nelson,
  Director
• Robert C Buhrmaster,
  Director
• Eugene C. Rusch,
  VP, Manufacturing
• Value Lp Starboard Value Gp...,
  
• Philip D Ankeny,
  Chief Financial Officer
• Jeffrey C Smith,
  Director
• John A Meslow,
  Director
• Jan M Webster,
  Vice President, HR
• Arthur J Tipton,
  Vice President
• Kenneth H Keller,
  Director